Enlivex ENLV
NASDAQ ENLV
$0.42 -0.08 (-15.93%)
At close: Oct 1, 2026 · 4:00 PM EDT

Enlivex (ENLV) Other Non-Current Liabilities (2017 - 2026)

Updated

Enlivex's Other Non-Current Liabilities was $128,000 in Q2 2026, down 40.7% from $216,000 a year earlier.

Analysis

Enlivex (ENLV) Other Non-Current Liabilities (2017 - 2026) Analysis & Trends

At the end of FY2024, Other Non-Current Liabilities at Enlivex came in at $299,000, down 56.4% from FY2023.

  • Other Non-Current Liabilities shows a five-year compound annual growth rate of 0.1% (FY2019 to FY2024).
  • In earlier years, Other Non-Current Liabilities was $686,000 in FY2023 (-83.6%) and $4.19 million in FY2022.
  • The Q2 2026 figure marks the lowest quarterly Other Non-Current Liabilities in data going back to Q4 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Enlivex 1.52 Mn -54.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 128,000.00
Jun 30, 2025 216,000.00
Dec 31, 2024 299,000.00
Jun 30, 2024 499,000.00
Dec 31, 2023 686,000.00
Dec 31, 2022 4.19 Mn
Dec 31, 2019 298,000.00
Dec 31, 2018 192,000.00
Sep 30, 2018 255,000.00
Dec 31, 2017 344,000.00
API Access

Enlivex Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ENLV&period=max&api_key=YOUR_API_KEY